Summary

The global Molecular Diagnostics in Infectious Disease Testing Market is projected to reach a valuation of US$ 67 Bn by 2025 and is estimated to grow to US$ 95 Bn by 2032, registering a CAGR of 5.11% during the forecast period. The market is gaining momentum as healthcare systems worldwide continue to adopt rapid and accurate diagnostic solutions for early disease detection. Increasing infectious disease prevalence and rising demand for point-of-care testing are among the primary factors supporting market expansion.

________________________________________

Molecular Diagnostics in Infectious Disease Testing Market – Report Scope:

The market for molecular diagnostics in infectious disease testing includes technologies and tools designed to detect nucleic acids from bacteria, viruses, and other pathogens. Techniques such as PCR, isothermal amplification, and next-generation sequencing (NGS) enable highly accurate and early diagnosis of infections including HIV, hepatitis, tuberculosis, and hospital-acquired infections. With growing emphasis on clinical efficiency and precision medicine, the adoption of molecular diagnostics is accelerating across hospitals, laboratories, and point-of-care settings globally.

________________________________________

Market Growth Drivers:

The rapid rise in infectious diseases globally is a primary factor driving the market. Enhanced awareness of early diagnosis, coupled with increasing demand for fast and reliable testing methods, is fueling the adoption of molecular diagnostics. Technological advancements—particularly in multiplex assays and portable platforms—are streamlining the diagnostic process. Additionally, government funding and initiatives for pandemic preparedness and infectious disease management continue to encourage innovation and infrastructure development. The COVID-19 pandemic has further validated the critical role of molecular testing, establishing long-term growth potential.

________________________________________

Market Restraints:

Despite robust growth potential, the market faces several limitations. High costs associated with molecular diagnostic equipment, reagents, and maintenance restrict accessibility in low-income and rural regions. The need for skilled professionals to operate and interpret results adds to the operational complexity. Inconsistent regulatory frameworks and reimbursement policies across countries pose further challenges for market penetration. Moreover, smaller healthcare providers may struggle with the technological and financial demands of adopting molecular diagnostic platforms.

________________________________________

Market Opportunities:

Rising demand for decentralized testing solutions presents significant opportunities, especially in emerging economies. Innovations in point-of-care molecular platforms and mobile diagnostics are making advanced testing more accessible and affordable. The integration of artificial intelligence and digital health platforms into molecular diagnostics is also opening new frontiers for predictive and personalized care. Expanding applications into non-infectious disease areas such as oncology and genetic disorders may further unlock untapped market potential. Additionally, growing partnerships between governments and private players to develop region-specific infectious disease panels create fertile ground for product innovation and expansion.

________________________________________

Regional Outlook:

North America currently leads the global market due to well-established healthcare systems, early adoption of advanced technologies, and strong investment in research and diagnostics. Europe follows with steady growth driven by public health initiatives and regulatory support. The Asia Pacific region is expected to witness the fastest growth, propelled by increasing healthcare awareness, large patient populations, and government-led disease surveillance programs. Meanwhile, Latin America and the Middle East & Africa are emerging as key regions with expanding diagnostic infrastructure and a growing focus on infectious disease management.

________________________________________

Leading Companies:

Leading companies in the global Molecular Diagnostics in Infectious Disease Testing Market are heavily focused on product innovation, strategic collaborations, and global expansion to strengthen their market positions. Key players include:

• Abbott Laboratories

• Becton, Dickinson and Company

• bioMérieux

• Thermo Fisher Scientific Inc.

• F. Hoffmann-La Roche Ltd

• Siemens AG

• Veridex, LLC

• Luminex Corp.

• GenMark Diagnostics, Inc.

• Qiagen N.V.

• Genomix Biotech

• bioTheranostics

These companies are continuously investing in expanding their assay portfolios, enhancing automation, and strengthening distribution networks to serve both high-income and emerging markets.

________________________________________

Market Segmentation:

By Product:

• Instruments and Analyzers

• Assays and Reagents

• Services and Software

By Application:

• Hepatitis B

• Hepatitis C

• AIDS

• Tuberculosis

• Methicillin-Resistant Staphylococcus Aureus (MRSA)

• Hospital-Acquired Infections

• Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)

• Human Papillomavirus (HPV) Infection

• Others

By Technique:

• Polymerase Chain Reaction (PCR)

• Isothermal Nucleic Acid Amplification Technology (INAAT)

• Microarrays

• Next-Generation Sequencing (NGS)

• Hybridization

• Others

By End User:

• Hospitals

• Private Labs

• Clinics

• Academic Institutes

• Laboratories

• Others

By Region:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Molecular Diagnostics in Infectious Disease Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Molecular Diagnostics in Infectious Disease Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Molecular Diagnostics in Infectious Disease Testing Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
5.1. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Instruments and Analyzers
5.1.1.2. Assays and Reagents
5.1.1.3. Services and Software
5.2. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hepatitis B
5.2.1.2. Hepatitis C
5.2.1.3. AIDS
5.2.1.4. Tuberculosis
5.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.1.6. Hospital-Acquired Infections
5.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
5.2.1.8. Human Papillomavirus (HPV) Infection
5.2.1.9. Others
5.3. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Polymerase Chain Reaction (PCR)
5.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3.1.3. Microarrays
5.3.1.4. Next-Generation Sequencing (NGS)
5.3.1.5. Hybridization
5.3.1.6. Others
5.4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Private Labs
5.4.1.3. Clinics
5.4.1.4. Academic Institutes
5.4.1.5. Laboratories
5.4.1.6. Others
5.5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
6.1. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Instruments and Analyzers
6.1.1.2. Assays and Reagents
6.1.1.3. Services and Software
6.2. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hepatitis B
6.2.1.2. Hepatitis C
6.2.1.3. AIDS
6.2.1.4. Tuberculosis
6.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.1.6. Hospital-Acquired Infections
6.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.1.8. Human Papillomavirus (HPV) Infection
6.2.1.9. Others
6.3. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Polymerase Chain Reaction (PCR)
6.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.1.3. Microarrays
6.3.1.4. Next-Generation Sequencing (NGS)
6.3.1.5. Hybridization
6.3.1.6. Others
6.4. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Private Labs
6.4.1.3. Clinics
6.4.1.4. Academic Institutes
6.4.1.5. Laboratories
6.4.1.6. Others
6.5. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1. Key Highlights
6.5.1.1. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.3. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.4. U.S. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.5. Canada Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.6. Canada Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.7. Canada Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.8. Canada Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
7.1. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Instruments and Analyzers
7.1.1.2. Assays and Reagents
7.1.1.3. Services and Software
7.2. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Hepatitis B
7.2.1.2. Hepatitis C
7.2.1.3. AIDS
7.2.1.4. Tuberculosis
7.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
7.2.1.6. Hospital-Acquired Infections
7.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
7.2.1.8. Human Papillomavirus (HPV) Infection
7.2.1.9. Others
7.3. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Polymerase Chain Reaction (PCR)
7.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.3.1.3. Microarrays
7.3.1.4. Next-Generation Sequencing (NGS)
7.3.1.5. Hybridization
7.3.1.6. Others
7.4. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Private Labs
7.4.1.3. Clinics
7.4.1.4. Academic Institutes
7.4.1.5. Laboratories
7.4.1.6. Others
7.5. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Germany Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.2. Germany Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.3. Germany Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.4. Germany Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.5. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.6. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.7. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.9. France Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.10. France Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.11. France Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.12. France Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.13. Italy Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.14. Italy Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.15. Italy Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.16. Italy Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.17. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.18. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.19. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.20. Turkey Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.21. Russia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.22. Russia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.23. Russia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.24. Russia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.25. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.26. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.27. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.28. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
8.1. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Instruments and Analyzers
8.1.1.2. Assays and Reagents
8.1.1.3. Services and Software
8.2. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hepatitis B
8.2.1.2. Hepatitis C
8.2.1.3. AIDS
8.2.1.4. Tuberculosis
8.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
8.2.1.6. Hospital-Acquired Infections
8.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
8.2.1.8. Human Papillomavirus (HPV) Infection
8.2.1.9. Others
8.3. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Polymerase Chain Reaction (PCR)
8.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.1.3. Microarrays
8.3.1.4. Next-Generation Sequencing (NGS)
8.3.1.5. Hybridization
8.3.1.6. Others
8.4. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Private Labs
8.4.1.3. Clinics
8.4.1.4. Academic Institutes
8.4.1.5. Laboratories
8.4.1.6. Others
8.5. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1. Key Highlights
8.5.1.1. China Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.2. China Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.3. China Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.4. China Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.5. Japan Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.6. Japan Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.7. Japan Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.8. Japan Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.9. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.10. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.11. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.12. South Korea Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.13. India Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.14. India Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.15. India Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.16. India Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.17. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.18. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.19. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.20. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.21. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.22. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.23. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.24. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
9.1. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Instruments and Analyzers
9.1.1.2. Assays and Reagents
9.1.1.3. Services and Software
9.2. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Hepatitis B
9.2.1.2. Hepatitis C
9.2.1.3. AIDS
9.2.1.4. Tuberculosis
9.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
9.2.1.6. Hospital-Acquired Infections
9.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
9.2.1.8. Human Papillomavirus (HPV) Infection
9.2.1.9. Others
9.3. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Polymerase Chain Reaction (PCR)
9.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.1.3. Microarrays
9.3.1.4. Next-Generation Sequencing (NGS)
9.3.1.5. Hybridization
9.3.1.6. Others
9.4. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Private Labs
9.4.1.3. Clinics
9.4.1.4. Academic Institutes
9.4.1.5. Laboratories
9.4.1.6. Others
9.5. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1. Key Highlights
9.5.1.1. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.2. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.3. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.4. Brazil Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.5. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.6. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.7. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.8. Mexico Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.9. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.10. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.11. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.12. Argentina Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.13. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.14. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.15. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.16. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2019-2032
10.1. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. Instruments and Analyzers
10.1.1.2. Assays and Reagents
10.1.1.3. Services and Software
10.2. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Hepatitis B
10.2.1.2. Hepatitis C
10.2.1.3. AIDS
10.2.1.4. Tuberculosis
10.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
10.2.1.6. Hospital-Acquired Infections
10.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
10.2.1.8. Human Papillomavirus (HPV) Infection
10.2.1.9. Others
10.3. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Polymerase Chain Reaction (PCR)
10.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.1.3. Microarrays
10.3.1.4. Next-Generation Sequencing (NGS)
10.3.1.5. Hybridization
10.3.1.6. Others
10.4. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Private Labs
10.4.1.3. Clinics
10.4.1.4. Academic Institutes
10.4.1.5. Laboratories
10.4.1.6. Others
10.5. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1. Key Highlights
10.5.1.1. GCC Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.2. GCC Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.3. GCC Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.4. GCC Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.5. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.6. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.7. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.8. South Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.9. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.10. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.11. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.12. Egypt Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.13. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.14. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.15. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.16. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.17. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.18. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.19. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.20. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Technique vs Application Heatmap
11.2. Company Market Share Analysis, 2025
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Becton
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Dickinson and Company
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. bioMérieux
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Thermo Fisher Scientific Inc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. F. Hoffmann-La Roche Ltd
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Siemens AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Veridex, LLC
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Luminex Corp.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. GenMark Diagnostics, Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Qiagen N.V.
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Genomix Biotech
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. bioTheranostics
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations